Zhongshuai Pharmaceutical Technology

Shanghai Zhongshuai Pharmaceutical Technology is a specialized pharmaceutical enterprise focused on the research, development, and manufacturing of advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Based in Shanghai, the company provides contract research (CRO) and contract development and manufacturing (CDMO) services to the global life sciences industry. Their expertise lies in complex organic synthesis, particularly for small molecule drugs targeting oncology and other critical therapeutic areas. Zhongshuai maintains a robust catalog of high-purity intermediates used in the production of blockbuster drugs such as BTK inhibitors. The company operates modern R&D laboratories and manufacturing facilities to support clients from early-stage discovery through commercial production.